Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
- Disclosed ownership: 9.8%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 9.8% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9.8% | 13,496,208 | 0 | 13,496,208 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 9.8% | 13,496,208 | 0 | 13,496,208 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 4.9% | 6,765,438 | 0 | 6,765,438 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.9% | 5,397,770 | 0 | 5,397,770 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.7% | 999,750 | 0 | 999,750 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0.3% | 333,250 | 0 | 333,250 | /s/ Kevin Tang | Chief Executive Officer |